NCT02966951

Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Knee Osteoarthrosis (KOA) in Jordanian Patients: a Phase I Dose-finding Study Using Adipose Tissue Derived Mesenchymal Stem Cells (ATMSC) for Advanced Stage III and IV KOA

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Hanan Jafar · Academic / Other
• Sex: All
• Age: 42 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Adipose tissue derived Mesenchymal Stem cells (ATMSC) will be injected in patients diagnosed with Knee osteoarthrosis

Detailed description

Ten patients from both genders diagnosed with Knee osteoarthrosis, will be enrolled according to specific inclusion and exclusion criteria. These patients will be injected with Adipose Tissue derived Mesenchymal Stem Cells. Then, they are followed by clinical assessment, laboratory investigations as well as magnetic resonance imaging (MRI) of the injected knee.

Conditions

• Knee Osteoarthrosis

Interventions

Type	Name	Description
BIOLOGICAL	Adipose tissue derived mesenchymal stem cell	Intra-articular adipose tissue derived mesenchymal stem cell injection.

Timeline

• Start date: 2017-01-17
• Primary completion: 2021-09-01
• Completion: 2021-12-01
• First posted: 2016-11-17
• Last updated: 2021-04-28

Locations

1 site across 1 country: Jordan